BL-6020

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameBL-6020

Drug Alias NameMC4-R antagonists (Santhera/ BioLineRx)MC4-R antagonists (Santhera)melanocortin 4 receptor antagonists (Santhera)SNT-207707SNT-207979 +[8]

ClassificationSmall molecules > Peptidomimetic

Mechanisms of ActionMelanocortin receptor 4 antagonistsAppetite stimulants

TargetsMelanocortin receptor 4

Therapy Area/IndicationsAnorexia NervosaCachexia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerlandIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanthera Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanthera Pharmaceuticals Biolinerx Ltd

Active IndicationsN/A

Inactive IndicationsAnorexia NervosaCachexia

Other Information

ATC CodeN/A